Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	21.68	64.77	53.23
Graham Fair Price	-35.71	10.54	16.39
PEG	817.99	-0.07	< 0.005
Price/Book	-8.47	0.72	0.78
Price/Cash Flow	62.26	18.45	11.37
Prices/Earnings	130.59	10.22	-4.43
Price/Sales	93.71	7.88	4.07
Price/FCF	62.26	18.45	11.37
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	67.13	0.40	0.24
Operating Margin	60.22	0.29	0.18
ROA	-59.24	< 0.005	-0.02
ROE	-0.04	0.02	-60.31
ROIC	0.01	0.01	-22.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.04	39.41
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.78	-0.23	-70.85
EPS QOQ	-5.56	1.40	-74.88
FCF QOQ	4.53	-0.42	-90.63
Revenue QOQ	1.02	-0.52	-49.17
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	134.78	334.08	147.87
Days Sales Outstanding (DSO)	13.89	12.63	-9.12
Inventory Turnover	0.67	0.27	-59.66
Debt/Capitalization	0.53	0.52	-1.82
Quick Ratio	0.28	0.31	10.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.44	16.78	2.04
Cash	0.73	1.06	43.94
Capex	-0.01	-0.01	-0.47
Free Cash Flow	1.13	0.65	-42.44
Revenue	3.17	1.53	-51.78
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.22	1.28	4.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.17	38.27	22.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating